14
Articles
417
Citations
1.9
avg. Impact Factor
10
h-index
Most Cited Articles of Department of Clinical Biochemistry in 2010
| Title | Journal | Year | Citations |
|---|---|---|---|
| Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk" | Circulation: Cardiovascular Quality and Outcomes | 2010 | 47 |